Personal information

Emails & domains

Verified email addresses

Verified email domains

Activities

Collapse all

Works (24)

YAP1 Inhibition Induces Phenotype Switching of Cancer-Associated Fibroblasts to Tumor Suppressive in Prostate Cancer.

Cancer research
2024-11-01 | Journal article | Author
DOI: 10.1158/0008-5472.can-24-0932
PMID: 39137404
PMC: PMC11565174
Contributors: Hongtao Song; Tong Lu; donghui Han; Jiayu Zhang; Lunbiao Gan; Chao Xu; Shaojie Liu; PENG LI; Keying Zhang; Zhihao Hu et al.
Source: Self-asserted source
JingLiang Zhang

Plasma exchange and intravenous immunoglobulin prolonged the survival of a porcine kidney xenograft in a sensitized, deceased human recipient.

Chinese medical journal
2024-10-18 | Journal article
DOI: 10.1097/cm9.0000000000003338
PMID: 39420636
Contributors: Ma S; Qi R; Han S; Li Z; Zhang X; Wang G; Liu K; Xu T; Zhang Y; Han D et al.
Source: Self-asserted source
JingLiang Zhang

The impact of integrating PRIMARY score or SUVmax with MRI-based risk models for the detection of clinically significant prostate cancer.

European journal of nuclear medicine and molecular imaging
2024-09-12 | Journal article | Author
DOI: 10.1007/s00259-024-06916-2
PMID: 39264425
Contributors: Guo S; Ren J; Meng Q; Zhang B; Jiao J; Han D; Wu P; Ma S; Zhang J; Xing N et al.
Source: Self-asserted source
JingLiang Zhang

Genetically Engineered Membrane-Coated Nanoparticles for Enhanced Prostate-Specific Membrane Antigen Targeting and Ferroptosis Treatment of Castration-Resistant Prostate Cancer.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
2024-07-01 | Journal article
DOI: 10.1002/advs.202401095
PMID: 38946578
PMC: PMC11434221
Contributors: Yu Li; Li H; Zhang K; Xu C; Wang J; Li Z; Zhou Y; Liu S; Zhao X; Li Z et al.
Source: Self-asserted source
JingLiang Zhang

Bi-Parameter MRI Could Quantitatively Assess the Zonal Heterogeneity of Prostate Cancer.

Clinical genitourinary cancer
2024-06-04 | Journal article
DOI: 10.1016/j.clgc.2024.102135
PMID: 38917763
Contributors: Han Y; Yuan L; Zhang J; Xiao Z; Jiao J; Shen F; Qin W; Huan Y; Ren J
Source: Self-asserted source
JingLiang Zhang

Detecting MRI-Invisible Prostate Cancers Using a Weakly Supervised Deep Learning Model

International Journal of Biomedical Imaging
2024-03-19 | Journal article
DOI: 10.1155/2024/2741986
Contributors: Yao Zheng; Jingliang Zhang; Dong Huang; Xiaoshuo Hao; Weijun Qin; Yang Liu; Vincenzo Positano
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Avoiding unnecessary biopsy: the combination of PRIMARY score with prostate-specific antigen density for prostate biopsy decision.

Prostate cancer and prostatic diseases
2023-12-30 | Journal article
DOI: 10.1038/s41391-023-00782-z
PMID: 38160227
Contributors: Guo S; Zhang J; Wang Y; Jiao J; Li Z; Cui C; Chen J; Yang W; Ma S; Wu P et al.
Source: Self-asserted source
JingLiang Zhang

Efficacy and Safety of Disitamab Vedotin Combined with Programmed Death-1 Inhibitor for Advanced Urothelial Cancer: A Case-Series Study.

Advances in therapy
2023-12-04 | Journal article
DOI: 10.1007/s12325-023-02729-1
PMID: 38048019
Contributors: Zhao H; Xu Z; Li C; Xu T; Zhang J; Jiao J; Yang B; Qin R; Yang L; Qin W et al.
Source: Self-asserted source
JingLiang Zhang

The PRIMARY Score: Diagnostic Performance and Added Value Compared With MRI in Detecting Clinically Significant Prostate Cancer.

Clinical nuclear medicine
2023-11-29 | Journal article
DOI: 10.1097/rlu.0000000000004951
PMID: 38081190
Contributors: Guo S; Kang F; Ma S; Jiao J; Ren J; Wang J; Zhang J; Qin W
Source: Self-asserted source
JingLiang Zhang

A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
2023-08-31 | Journal article
DOI: 10.2967/jnumed.122.265001
PMID: 37652543
Contributors: Zhang J; Kang F; Gao J; Jiao J; Quan Z; Ma S; Li Y; Guo S; Li Z; Jing Y et al.
Source: Self-asserted source
JingLiang Zhang

Cross-disease characterization of fibroblast heterogeneities and their pathogenic roles in skin inflammation.

Clinical immunology (Orlando, Fla.)
2023-08-17 | Journal article
DOI: 10.1016/j.clim.2023.109742
PMID: 37595936
Contributors: Li Z; Cao T; Li Q; Zhang J; Du J; Chen J; Bai Y; Hao J; Zhu Z; Qiao H et al.
Source: Self-asserted source
JingLiang Zhang

PI-RADS-Based Segmented Threshold of PSMA-PET SUVmax Is Better than Traditional Fixed Threshold for Diagnosing Clinically Significant Prostate Cancer Especially for PI-RADS 3 Lesions.

Molecular imaging and biology
2023-07-25 | Journal article
DOI: 10.1007/s11307-023-01841-6
PMID: 37490189
Contributors: Meng X; Ma W; Zhang J; Quan Z; Zhang M; Ye J; Shu J; Ren J; Qin W; Fei Kang et al.
Source: Self-asserted source
JingLiang Zhang

Comparison of prostate volume measured by transabdominal ultrasound and MRI with the radical prostatectomy specimen volume: a retrospective observational study.

BMC urology
2023-04-17 | Journal article
DOI: 10.1186/s12894-023-01234-5
PMID: 37069539
PMC: PMC10111778
Contributors: Guo S; Zhang J; Jiao J; Li Z; Wu P; Jing Y; Qin W; Wang F; Ma S
Source: Self-asserted source
JingLiang Zhang

VIM‑AS1 promotes proliferation and drives enzalutamide resistance in prostate cancer via IGF2BP2‑mediated HMGCS1 mRNA stabilization.

International journal of oncology
2023-02-03 | Journal article
DOI: 10.3892/ijo.2023.5482
PMID: 36734275
PMC: PMC9911078
Contributors: Shi SJ; Han DH; Zhang JL; Li Y; Yang AG; Zhang R
Source: Self-asserted source
JingLiang Zhang

Photodynamic therapy for prostate cancer: Recent advances, challenges and opportunities.

Frontiers in oncology
2022-09-23 | Journal article
DOI: 10.3389/fonc.2022.980239
PMID: 36212416
PMC: PMC9538922
Contributors: Xue Q; Zhang J; Jiao J; Qin W; Yang X
Source: Self-asserted source
JingLiang Zhang

Prostate specific membrane antigen positron emission tomography in primary prostate cancer diagnosis: First-line imaging is afoot.

Cancer letters
2022-08-24 | Journal article
DOI: 10.1016/j.canlet.2022.215883
PMID: 36027998
Contributors: Jiao J; Zhang J; Li Z; Wen W; Cui C; Zhang Q; Wang J; Weijun Qin
Source: Self-asserted source
JingLiang Zhang

Establishment and prospective validation of an SUV<sub>max</sub> cutoff value to discriminate clinically significant prostate cancer from benign prostate diseases in patients with suspected prostate cancer by <sup>68</sup>Ga-PSMA PET/CT: a real-world study.

Theranostics
2021-07-25 | Journal article
DOI: 10.7150/thno.58140
PMID: 34373749
PMC: PMC8344003
Contributors: Jiao J; Fei Kang; Zhang J; Quan Z; Wen W; Zhao X; Ma S; Wu P; Yang F; Guo W et al.
Source: Self-asserted source
JingLiang Zhang

The Establishment of New Thresholds for PLND-Validated Clinical Nomograms to Predict Non-Regional Lymph Node Metastases: Using <sup>68</sup>Ga-PSMA PET/CT as References.

Frontiers in oncology
2021-04-15 | Journal article
DOI: 10.3389/fonc.2021.658669
PMID: 33937073
PMC: PMC8082014
Contributors: Jiao J; Quan Z; Zhang J; Wen W; Qin J; Yang L; Meng P; Jing Y; Ma S; Wu P et al.
Source: Self-asserted source
JingLiang Zhang

Interaction with CD68 and Regulation of GAS6 Expression by Endosialin in Fibroblasts Drives Recruitment and Polarization of Macrophages in Hepatocellular Carcinoma

Cancer Research
2020-09-15 | Journal article
DOI: 10.1158/0008-5472.CAN-19-2691
Contributors: Fa Yang; Yan Wei; Donghui Han; Yu Li; Shengjia Shi; Dian Jiao; Jieheng Wu; Qiang Zhang; Changhong Shi; Lijun Yang et al.
Source: check_circle
Crossref

Quicker, deeper and stronger imaging: A review of tumor-targeted, near-infrared fluorescent dyes for fluorescence guided surgery in the preclinical and clinical stages.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
2020-05-08 | Journal article
DOI: 10.1016/j.ejpb.2020.05.002
PMID: 32437752
Contributors: Jiao J; Zhang J; Yang F; Song W; Han D; Wen W; Qin W
Source: Self-asserted source
JingLiang Zhang

Neutrophil exosomes enhance the skin autoinflammation in generalized pustular psoriasis <i>via</i> activating keratinocytes.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2019-02-27 | Journal article
DOI: 10.1096/fj.201802090rr
PMID: 30811955
Contributors: Shao S; Fang H; Zhang J; Jiang M; Xue K; Ma J; Zhang J; Lei J; Zhang Y; Bing Li et al.
Source: Self-asserted source
JingLiang Zhang

Therapeutic effects of human monoclonal PSMA antibody-mediated TRIM24 siRNA delivery in PSMA-positive castration-resistant prostate cancer.

Theranostics
2019-02-07 | Journal article
DOI: 10.7150/thno.29884
PMID: 30867828
PMC: PMC6401511
Contributors: Shi SJ; Wang LJ; Han DH; Jieheng Wu; Jiao D; Zhang KL; Chen JW; Li Y; Yang F; Zhang JL et al.
Source: Self-asserted source
JingLiang Zhang

Diagnostic performance of <sup>68</sup>Ga-PSMA PET/CT in the detection of prostate cancer prior to initial biopsy: comparison with cancer-predicting nomograms.

European journal of nuclear medicine and molecular imaging
2019-01-11 | Journal article
DOI: 10.1007/s00259-018-4255-1
PMID: 30635755
Contributors: Zhang J; Shao S; Wu P; Liu D; Yang B; Han D; Li Y; Lin X; Song W; Cao M et al.
Source: Self-asserted source
JingLiang Zhang

High mobility group box 1 promotes the epithelial-to-mesenchymal transition in prostate cancer PC3 cells via the RAGE/NF-κB signaling pathway.

International journal of oncology
2018-05-23 | Journal article
DOI: 10.3892/ijo.2018.4420
PMID: 29845254
PMC: PMC6017266
Contributors: Zhang J; Shao S; Han D; Xu Y; Jiao D; Jieheng Wu; Yang F; Ge Y; Shi S; Li Y et al.
Source: Self-asserted source
JingLiang Zhang

Peer review (1 review for 1 publication/grant)

Review activity for European journal of nuclear medicine and molecular imaging. (1)
How many people are using ORCID?